vs

Side-by-side financial comparison of TriSalus Life Sciences, Inc. (TLSI) and TIMBERLAND BANCORP INC (TSBK). Click either name above to swap in a different company.

TIMBERLAND BANCORP INC is the larger business by last-quarter revenue ($21.7M vs $13.2M, roughly 1.6× TriSalus Life Sciences, Inc.). TIMBERLAND BANCORP INC runs the higher net margin — 37.8% vs -73.9%, a 111.7% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 10.4%). TIMBERLAND BANCORP INC produced more free cash flow last quarter ($5.6M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 9.1%).

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

Timberland Bancorp Inc is a U.S.-based bank holding company operating primarily across Washington state. It provides a full range of personal and commercial banking services including checking and savings accounts, residential and commercial mortgages, small business loans, and wealth management solutions for local retail and small to mid-sized business clients.

TLSI vs TSBK — Head-to-Head

Bigger by revenue
TSBK
TSBK
1.6× larger
TSBK
$21.7M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+49.4% gap
TLSI
59.8%
10.4%
TSBK
Higher net margin
TSBK
TSBK
111.7% more per $
TSBK
37.8%
-73.9%
TLSI
More free cash flow
TSBK
TSBK
$8.1M more FCF
TSBK
$5.6M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
9.1%
TSBK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
TLSI
TLSI
TSBK
TSBK
Revenue
$13.2M
$21.7M
Net Profit
$-9.8M
$8.2M
Gross Margin
86.7%
Operating Margin
-24.8%
Net Margin
-73.9%
37.8%
Revenue YoY
59.8%
10.4%
Net Profit YoY
3.5%
19.8%
EPS (diluted)
$-0.22
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TLSI
TLSI
TSBK
TSBK
Q4 25
$13.2M
$21.7M
Q3 25
$11.6M
$22.5M
Q2 25
$11.2M
$20.5M
Q1 25
$9.2M
$19.9M
Q4 24
$8.3M
$19.7M
Q3 24
$7.3M
$19.5M
Q2 24
$7.4M
$18.8M
Q1 24
$6.5M
$18.3M
Net Profit
TLSI
TLSI
TSBK
TSBK
Q4 25
$-9.8M
$8.2M
Q3 25
$-10.8M
$8.4M
Q2 25
$-8.3M
$7.1M
Q1 25
$-10.4M
$6.8M
Q4 24
$-10.1M
$6.9M
Q3 24
$-2.4M
$6.4M
Q2 24
$-4.3M
$5.9M
Q1 24
$-13.2M
$5.7M
Gross Margin
TLSI
TLSI
TSBK
TSBK
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
TLSI
TLSI
TSBK
TSBK
Q4 25
-24.8%
Q3 25
-77.9%
Q2 25
-65.4%
Q1 25
-79.9%
Q4 24
-91.8%
Q3 24
-118.9%
Q2 24
-111.0%
Q1 24
-180.8%
Net Margin
TLSI
TLSI
TSBK
TSBK
Q4 25
-73.9%
37.8%
Q3 25
-93.5%
37.6%
Q2 25
-73.9%
34.6%
Q1 25
-113.2%
33.9%
Q4 24
-122.4%
34.9%
Q3 24
-32.6%
32.6%
Q2 24
-58.8%
31.6%
Q1 24
-204.5%
31.3%
EPS (diluted)
TLSI
TLSI
TSBK
TSBK
Q4 25
$-0.22
$1.04
Q3 25
$-0.96
$1.06
Q2 25
$-0.27
$0.90
Q1 25
$-0.39
$0.85
Q4 24
$-0.38
$0.86
Q3 24
$-0.12
$0.80
Q2 24
$-0.21
$0.74
Q1 24
$-0.60
$0.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TLSI
TLSI
TSBK
TSBK
Cash + ST InvestmentsLiquidity on hand
$20.4M
$246.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-33.9M
$268.4M
Total Assets
$35.3M
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TLSI
TLSI
TSBK
TSBK
Q4 25
$20.4M
$246.9M
Q3 25
$22.7M
$243.4M
Q2 25
$26.5M
$193.6M
Q1 25
$13.0M
$191.2M
Q4 24
$8.5M
$164.1M
Q3 24
$11.3M
$164.7M
Q2 24
$16.5M
$158.9M
Q1 24
$4.0M
$180.3M
Stockholders' Equity
TLSI
TLSI
TSBK
TSBK
Q4 25
$-33.9M
$268.4M
Q3 25
$-26.7M
$262.6M
Q2 25
$-19.4M
$256.7M
Q1 25
$-34.4M
$252.5M
Q4 24
$-25.9M
$249.2M
Q3 24
$-20.4M
$245.4M
Q2 24
$-25.3M
$241.2M
Q1 24
$-36.0M
$238.7M
Total Assets
TLSI
TLSI
TSBK
TSBK
Q4 25
$35.3M
$2.0B
Q3 25
$36.5M
$2.0B
Q2 25
$41.3M
$2.0B
Q1 25
$28.6M
$1.9B
Q4 24
$24.0M
$1.9B
Q3 24
$27.5M
$1.9B
Q2 24
$32.4M
$1.9B
Q1 24
$17.9M
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TLSI
TLSI
TSBK
TSBK
Operating Cash FlowLast quarter
$-2.5M
$6.1M
Free Cash FlowOCF − Capex
$-2.5M
$5.6M
FCF MarginFCF / Revenue
-19.1%
25.7%
Capex IntensityCapex / Revenue
0.3%
2.3%
Cash ConversionOCF / Net Profit
0.74×
TTM Free Cash FlowTrailing 4 quarters
$-19.1M
$56.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TLSI
TLSI
TSBK
TSBK
Q4 25
$-2.5M
$6.1M
Q3 25
$-3.7M
$30.2M
Q2 25
$-7.3M
$10.8M
Q1 25
$-4.5M
$12.4M
Q4 24
$-5.7M
$-3.1M
Q3 24
$-10.8M
$23.0M
Q2 24
$-13.4M
$7.4M
Q1 24
$-10.9M
$4.1M
Free Cash Flow
TLSI
TLSI
TSBK
TSBK
Q4 25
$-2.5M
$5.6M
Q3 25
$-3.9M
$28.4M
Q2 25
$-7.4M
$10.3M
Q1 25
$-5.3M
$12.2M
Q4 24
$-5.8M
$-3.6M
Q3 24
$-11.0M
$21.7M
Q2 24
$-13.5M
$7.2M
Q1 24
$-10.9M
$3.6M
FCF Margin
TLSI
TLSI
TSBK
TSBK
Q4 25
-19.1%
25.7%
Q3 25
-33.9%
126.4%
Q2 25
-66.1%
50.5%
Q1 25
-57.3%
61.1%
Q4 24
-69.7%
-18.1%
Q3 24
-149.9%
111.5%
Q2 24
-183.1%
38.4%
Q1 24
-169.3%
19.8%
Capex Intensity
TLSI
TLSI
TSBK
TSBK
Q4 25
0.3%
2.3%
Q3 25
1.9%
7.7%
Q2 25
0.8%
2.1%
Q1 25
8.2%
1.0%
Q4 24
0.6%
2.6%
Q3 24
2.3%
6.7%
Q2 24
0.8%
1.1%
Q1 24
1.0%
2.7%
Cash Conversion
TLSI
TLSI
TSBK
TSBK
Q4 25
0.74×
Q3 25
3.57×
Q2 25
1.52×
Q1 25
1.83×
Q4 24
-0.45×
Q3 24
3.62×
Q2 24
1.25×
Q1 24
0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons